Clinical use of the "G-suit"

The "G-suit," a device for combating hypovolemic shock with external pneumatic counterpressure, represents an application of an old idea to a relatively common medical problem. Its simplicity of use and quick therapeutic effect buys time for the patient with hypovolemic shock, whether the suit is applied in the prehospital or emergency department setting.

[Clinical evaluation of glipizide. Results of a multicentric study in Spain]

In this study, with the evaluation of 621 diabetics under treatment, it is shown that glipizide is a potent oral sulfonilurea which controlled satisfactorily the blood sugar levels in 83,5% of diabetics without previous treatment, 67% of the cases with positive response to previous anti-diabetic therapy and 51,3% of the patients that had not responded to previous treatments. The most frecuently used dosage was 5 mg daily, with a minimum of 2,5 mg and a maximum of 30 mg. Tolerance and safety observed was excellent.